153 related articles for article (PubMed ID: 23940219)
1. Diagnosis and treatment of KIT-mutant metastatic melanoma.
Lyle M; Long GV
J Clin Oncol; 2013 Sep; 31(26):3176-81. PubMed ID: 23940219
[TBL] [Abstract][Full Text] [Related]
2. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
[TBL] [Abstract][Full Text] [Related]
3. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
Hodi FS; Corless CL; Giobbie-Hurder A; Fletcher JA; Zhu M; Marino-Enriquez A; Friedlander P; Gonzalez R; Weber JS; Gajewski TF; O'Day SJ; Kim KB; Lawrence D; Flaherty KT; Luke JJ; Collichio FA; Ernstoff MS; Heinrich MC; Beadling C; Zukotynski KA; Yap JT; Van den Abbeele AD; Demetri GD; Fisher DE
J Clin Oncol; 2013 Sep; 31(26):3182-90. PubMed ID: 23775962
[TBL] [Abstract][Full Text] [Related]
4. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
[TBL] [Abstract][Full Text] [Related]
5. Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.
Viray H; Bradley WR; Schalper KA; Rimm DL; Gould Rothberg BE
Arch Pathol Lab Med; 2013 Aug; 137(8):1063-73. PubMed ID: 23899062
[TBL] [Abstract][Full Text] [Related]
6. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.
Gos A; Jurkowska M; van Akkooi A; Robert C; Kosela-Paterczyk H; Koljenović S; Kamsukom N; Michej W; Jeziorski A; Pluta P; Verhoef C; Siedlecki JA; Eggermont AM; Rutkowski P
Ann Surg Oncol; 2014 Dec; 21(13):4317-23. PubMed ID: 24866436
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous regressing/regressed malignant melanoma: a clinicopathologic analysis of 8 cases].
Shen XX; Kong YY; Dai B; Cai X; Wang LW; Kong JC
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):675-8. PubMed ID: 24433730
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
[TBL] [Abstract][Full Text] [Related]
10. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
Khushalani NI
J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
[TBL] [Abstract][Full Text] [Related]
11. BRAF mutation-positive folliculotropic metastatic melanoma.
Brick KE; Halling KC; Khan YK; Peters MS
Am J Dermatopathol; 2013 Jul; 35(5):609-12. PubMed ID: 23715079
[TBL] [Abstract][Full Text] [Related]
12. BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients.
Oyama S; Funasaka Y; Watanabe A; Takizawa T; Kawana S; Saeki H
J Dermatol; 2015 May; 42(5):477-84. PubMed ID: 25766129
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].
Rose C
Pathologe; 2017 Feb; 38(1):49-61. PubMed ID: 28154916
[TBL] [Abstract][Full Text] [Related]
14. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes.
Willis BC; Johnson G; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):109-12. PubMed ID: 25356946
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].
Rose C
Hautarzt; 2017 Sep; 68(9):749-761. PubMed ID: 28875289
[TBL] [Abstract][Full Text] [Related]
16. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
[TBL] [Abstract][Full Text] [Related]
17. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
Kimbrough CW; Egger ME; McMasters KM; Stromberg AJ; Martin RC; Philips P; Scoggins CR
J Am Coll Surg; 2016 Apr; 222(4):357-63. PubMed ID: 26875070
[TBL] [Abstract][Full Text] [Related]
18. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2014; 22(2):142-5. PubMed ID: 23958542
[TBL] [Abstract][Full Text] [Related]
19. Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma?
Kucher C; Zhang PJ; Acs G; Roberts S; Xu X
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):324-7. PubMed ID: 16932024
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy between fluorescence in situ hybridization and multiplex ligation-dependent probe amplification in orbital recurrence of uveal melanoma 26 years after enucleation.
Russo A; Rene C; Coupland SE; Sagili S; Damato B
Ophthalmic Plast Reconstr Surg; 2012; 28(6):e140-2. PubMed ID: 22460679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
